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Abstract
Purpose The Effective Consumer Scale (EC-17) mea-
sures the skills of musculoskeletal patients in managing
their own healthcare. The objectives of this study were to
translate the EC-17 into Dutch and to further evaluate its
psychometric properties.
Methods The EC-17 was translated and cognitively pre-
tested following cross-cultural adaptation guidelines. Two
hundred and thirty-eight outpatients (52 % response rate)
with osteoarthritis or fibromyalgia completed the EC-17
along with other validated measures. Three weeks later,
101 patients completed the EC-17 again.
Results Confirmatory factor analysis supported the uni-
dimensional structure of the scale. The items adequately fit
the Rasch model and only one item demonstrated differ-
ential item functioning. Person reliability was high (0.92),
but item difficulty levels tended to cluster around the
middle of the scale, and measurement precision was
highest for moderate and lower levels of skills. The scale
demonstrated adequate test–retest reliability (ICC = 0.71),
and correlations with other measures were largely as
expected.
Conclusion The results supported the validity and reli-
ability of the Dutch version of the EC-17, but suggest that
the scale is best targeted at patients with relatively low
levels of skills. Future studies should further examine its
sensitivity to change in a clinical trial specifically aimed at
improving effective consumer skills.
Keywords Arthritis  Consumer participation 
Psychometrics  Rasch analysis
Abbreviations
CFA Confirmatory factor analysis
DIF Differential item functioning
EC-17 17-item Effective Consumer Scale
FM Fibromyalgia




Self-management interventions are aimed at providing
patients with the necessary knowledge, skills, and confi-
dence to effectively manage their condition themselves.
The effectiveness of such interventions is typically evalu-
ated by a wide range of clinical severity measures, self-
reported symptoms, and presumed psychological mediators
such as self-efficacy [1–3]. To date, however, there is no
agreement on the actual set of attributes that are important
to managing and participating in healthcare and on how to
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measure these [4]. This makes it difficult to evaluate direct
effects on patient skills and to compare the results of var-
ious interventions.
To address this issue, the 17-item Effective Consumer
Scale (EC-17) was recently developed based on extensive
literature reviews, expert and patient interviews and pilot
testing [5]. A follow-up study explored its construct
validity and responsiveness in participants in the arthritis
self-management program (ASMP) [6]. Results showed
that the EC-17 addressed skills and behaviours not covered
by other relevant scales such as the Health Education
Impact Questionnaire [7], Patient Activation Measure [8],
and Arthritis Self-Efficacy Scale [9], including identifying
quality information and negotiation with health profes-
sionals [6]. Moreover, although the ASMP was not tailored
to all behaviours measured by the EC-17, the scale was
modestly sensitive to change [6]. A similar study exam-
ining the Norwegian EC-17 also showed that the scale was
easy to complete, internally consistent, reproducible, valid,
and moderately responsive to change [10]. The aim of this
study was to cross-culturally adapt the EC-17 for use in
Dutch patients with musculoskeletal conditions and to
evaluate its psychometric properties.
Materials and methods
Cross-cultural translation
Cross-cultural adaptation followed established forward–
backward translation procedures [11]. The prefinal EC-17
was cognitively pretested in five patient research partners
(four female, age range 29–74 years) with different rheu-
matic conditions. Pretests were carried out using the three-
step test interview method [12]. Based on the results, small
wording changes were made in six items (e.g., ‘arrange’
instead of ‘organise’), one response option (‘generally’
instead of ‘usually’), and the instructions (expanded with
an explanation of the term ‘management’).
Psychometric evaluation
Participants
A survey was sent in October 2010 to a random sample of
404 patients with osteoarthritis (OA) and 58 patients with
fibromyalgia (FM) that had visited the outpatient rheuma-
tology clinic in the preceding year. Two hundred and fifty-
three (54.8 %) patients returned a completed survey. The
first 120 patients willing to complete the scale a second
time were sent a follow-up questionnaire, which was
completed by 101 (84.2 %) patients after a median (IQR)
time of 20 (18–24) days.
Measures
The EC-17 measures knowledge, attitudes, and behaviours
about self-management skills using 17 items with 5-point
Likert-type scales (‘‘never’’ to ‘‘always’’) [5]. Item scores are
summed when C14 items are completed and converted to
range from 0 to 100, where 100 is the best possible score.
Additionally, patients completed the 5-item Perceived
Efficacy in Patient–Physician Interactions scale (PEPPI-5;
a = 0.90) [13, 14], the 12-item Dutch General Self-Effi-
cacy Scale (GSES; a = 0.80) [15, 16], the 4-item support
from family and friends subscale from the Arthritis Impact
Measurement Scales 2 (AIMS2; a = 0.91) [17, 18], and
the 36-Item Short Form Health Survey (SF-36v2) [19, 20],
from which the physical and mental component summary
(PCS and MCS) scores were calculated [21]. Pain in the
last week was measured on an 11-point numerical rating
scale (NRS) from 0 (‘no pain’) to 10 (‘unbearable pain’).
Data analysis
Fifteen patients had [3 missing values on the EC-17 and
were excluded from further analyses (final response rate
51.5 %). Remaining missing values were low, with a
maximum of five (2.1 %) for items 10 and 16, and were
imputed with their median values.
Unidimensionality of the EC-17 was tested using robust
maximum likelihood confirmatory factor analysis (CFA)
[22]. Non-normed (NNFI) and comparative fit (CFI)
indexes C0.95 and standardized root mean square residual
(SRMR) and root mean square error of approximation
(RMSEA) B0.08 and 0.06, respectively, were considered
indicative of good fit [23, 24].
Additionally, Rasch partial credit model analyses were
performed [25]. Conservative infit values between 0.87 and
1.13 and outfit values between 0.61 and 1.39 were considered
to indicate acceptable item fit [26]. Items with residual cor-
relations[0.30 were considered locally dependent [27, 28].
Differential item functioning (DIF) was evaluated across
sex, age, and disease duration and considered present when
the difference between the item calibrations was statistically
significant and[0.5 logits [25, 29]. Person reliability C0.70
and C0.85 was considered adequate for group-level and
individual comparisons, respectively [28]. The person-item
map and test information function were examined for mi-
stargeting and local measurement precision [30].
Reproducibility was assessed by intraclass correlation
(ICC, type A,1) [31] and considered adequate for group-
level and individual measurements over time when C0.70
and C0.90, respectively [32].
For convergent and discriminant validity, it was
hypothesized that an adequate measure of perceived health-
management skills should be strongly correlated with
424 Qual Life Res (2013) 22:423–429
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perceived effectiveness in patient–physician interaction,
which is an important aspect of general health-management
skills, and moderately correlated with the conceptually
related construct of general self-efficacy and social support
[33–35]. Finally, a moderate correlation with psychosocial
health (SF-36 MCS) and weak correlations with physical
health (SF-36 PCS) and pain were expected [36].
Results
Patient characteristics
Patient characteristics are reported in Table 1. There were
no significant differences with respect to age or sex
between the respondents and non-respondents. FM
patients differed significantly from OA patients on several







Age, years 62.6 ± 10.1 42.4 ± 14.4 \0.001 60.1 ± 12.6
Sex, female 169 (80.9 %) 25 (86.2 %) N.S. 194 (81.5 %)
Disease duration, years 10.9 ± 10.9 10.2 ± 10.1 N.S. 10.8 ± 10.8
Ethnicity, Dutch 198 (94.7 %) 27 (93.1 %) N.S. 225 (94.5 %)
Self-management training, yes 13 (6.2 %) 9 (31.0 %) \0.001 22 (9.2 %)
Marital status
Not married/not living together 4 (1.9 %) 6 (20.7 %) \0.001 10 (4.2 %)
Married/living together 158 (75.6 %) 20 (69.0 %) 178 (74.8 %)
Widowed/divorced 45 (21.6 %) 3 (10.3 %) 48 (20.2 %)
Education
Low 127 (60.7 %) 11 (37.9 %) 0.070 138 (58.0 %)
Medium 44 (21.1 %) 14 (48.3 %) 58 (24.4 %)
High 35 (16.8 %) 4 (13.8 %) 39 (16.4 %)
Occupational status
Full-time employed 25 (12.0 %) 2 (6.9 %) \0.001 27 (11.3 %)
Part-time employed 49 (23.4 %) 12 (41.4 %) 61 (25.6 %)
Homemaker 51 (24.4 %) 5 (17.2 %) 56 (23.5 %)
School 1 (0.5 %) 4 (13.8 %) 5 (2.1 %)
Unemployed/disabled/retired 80 (38.3 %) 6 (20.6 %) 86 (36.1 %)
EC-17 (range 0–100) 68.9 ± 16.3 62.3 ± 14.1 0.040 68.1 ± 16.1
PEPPI-5 (range 5–25) 18.7 ± 4.3 16.8 ± 3.1 0.005 18.5 ± 4.2
GSES (range 12–60) 42.8 ± 6.3 42.9 ± 7.5 N.S. 42.8 ± 6.5
AIMS2 Support (range 0–10) 3.7 ± 2.5 4.7 ± 2.4 0.039 3.8 ± 2.5
SF-36 PCS (range 0–100) 36.0 ± 9.2 35.7 ± 6.4 N.S. 35.9 ± 8.9
SF-36 MCS (range 0–100) 49.0 ± 10.6 43.7 ± 12.0 0.015 48.4 ± 10.9
NRS Pain (range 0–10) 5.7 ± 2.0 7.1 ± 1.2 \0.001 5.8 ± 2.0
Values are mean ± SD or number (%). OA osteoarthritis, FM fibromyalgia, PEPPI-5 perceived efficacy in patient–physician interactions scale,
EC-17 effective consumer scale, GSES general self-efficacy scale, AIMS2 arthritis impact measurement scales 2, SF-36 medical outcomes study
36-item short form, PCS physical component summary, MCS mental component summary, NRS numerical rating scale
Fig. 1 Distribution of EC-17 total scores
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socio-demographic variables and scored worse on all
scales, except the GSES and SF-36 PCS.
Distributional properties
Total scores on the EC-17 showed a near-normal distribution
(Kolmogorov–Smirnov, P = 0.058) with skewness and
kurtosis values of -0.72 and 0.74, respectively (Fig. 1).
Floor and ceiling effects were absent, with no patients
scoring zero and only three patients (1.3 %) scoring 100.
Unidimensionality
With the exception of RMSEA, the one-factor model
showed a good fit (SBv2(119) = 488.70, NNFI = 0.96,
CFI = 0.96, SRMR = 0.08, RMSEA (90 % CI) = 0.11
(0.10–0.12). Standardized factor loadings were high for all
items (Table 2).
Rasch measurement properties
The EC-17 adequately fit the Rasch model. Five items
showed infit values slightly outside the range of 0.87–1.13,
and no items showed poor outfit (Table 2). Residual cor-
relations revealed some redundancy or multidimensional-
ity, as demonstrated by 4 pairs of items showing positive
(r’s between 0.33 and 0.40) and 4 showing negative local
dependence (r’s between -0.31 and -0.32). No items
showed DIF across sex and disease duration and only one
item across age.









Absolute DIF in logits
Sexa Ageb Disease
durationc
16. I can negotiate with the healthcare system about what
to do to manage my disease
0.80 0.67 (0.09) 0.98 1.01 -0.14 0.15 -0.35
13. I feel a sense of control over my disease 0.73 0.56 (0.10) 1.09 1.15 -0.25 0.28 0.21
10. I am able to play the role I want to in my healthcare
team
0.71 0.36 (0.10) 1.06 1.12 0.11 -0.03 0.00
1. I know who can help me judge the quality of the
information I receive about my disease
0.66 0.36 (0.09) 1.19 1.33 -0.09 -0.29 -0.05
15. I can negotiate with others about what we need to do
to manage my disease
0.85 0.30 (0.10) 0.74 0.75 -0.03 0.06 0.00
17. I can organise my life to act on decisions about how to
manage my disease
0.82 0.22 (0.10) 0.86 0.80 -0.15 0.34 -0.09
11. I know who to work with to meet my health needs 0.76 0.19 (0.10) 0.91 0.88 -0.25 0.14 0.00
12. I can be assertive to get what I need to meet my health
needs (for example, information and treatments)
0.83 0.18 (0.10) 0.78 0.74 0.10 0.11 -0.13
6. I can set realistic goals about the management of my
disease
0.67 -0.01 (0.11) 1.09 1.03 0.05 -0.23 -0.02
4. I can be clear about what is important in my life when I
make decisions about my disease
0.68 -0.08 (0.12) 1.01 1.03 0.16 -0.20 0.18
9. I have built an open and trusting relationship, based on
mutual respect, with my healthcare providers
0.70 -0.15 (0.09) 1.13 1.20 -0.31 0.42 0.05
7. I can express my concerns well to healthcare providers 0.74 -0.26 (0.10) 0.97 1.01 0.35 0.24 -0.22
5. I can weigh the pros and cons of a decision about my
disease
0.70 -0.35 (0.11) 1.02 0.98 0.31 -0.18 0.23
8. I know how to ask good questions about my health and
my disease
0.77 -0.37 (0.11) 0.92 0.92 0.05 -0.31 -0.17
14. I feel confident in making decisions about my health 0.76 -0.39 (0.11) 0.97 0.94 0.00 0.33 -0.11
3. I know how to adapt general health information to my
own situation
0.68 -0.57 (0.11) 1.00 1.03 0.09 -0.48 0.46
2. I understand the information I receive about my disease 0.64 -0.68 (0.11) 1.17 1.09 0.29 -0.80* 0.21
Higher positive logit scores indicate more difficult items
a Male versus female; b median split B59 years versus [59 years; c median split B6 years versus [6 years
* Significant at Bonferroni adjusted level of P \ 0.001
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Internal consistency was sufficiently high (person reli-
ability = 0.92) for individual-level comparisons. Item
difficulty estimates ranged from 0.67 to -0.68 logits and
tended to cluster around the middle of the scale, with a
large proportion of patients with relatively high skills not
being covered by any individual item (Fig. 2). The mean
logit score for patients was 1.25, indicating that the sample
as a whole was located at a higher ability level than the
mean item difficulty.
The information curve (Fig. 3) was peaked at lower
levels of the underlying trait, indicating that patients with
skills below the mean are measured with more precision
than individuals with better skills. Measurement precision
was sufficient for group-level analyses across a wide range
of the underlying trait, but adequate for individual-level
comparisons in persons with moderate and lower levels of
self-management skills only.
Test–retest reliability
With an ICC of 0.71 (95 % CI: 0.60–0.80), test–retest
reliability of the scale was adequate for group-level
comparisons.
External construct validity
As expected, the EC-17 correlated strongly with perceived
efficacy in patient–physician interactions, moderately with
social support and psychosocial aspects of health, and
weakly with physical aspects of health and pain (Table 3).
Fig. 2 Distribution of person
abilities and item difficulties
across the scale. Higher positive
logit scores indicate better self-
management skills and more
difficult items. Mean person
ability = 1.25 (SD = 1.74);
mean item difficulty = 0.00
(SD = 0.39)
Fig. 3 Test information curve of the EC-17 in relation to the Rasch
score. Higher positive logit scores indicate better self-management
skills and attributes. Test information values of 3.33 and 6.67 (dotted
lines) correspond to a reliability of 0.70 and 0.85, respectively. Logit
values of -6, 0, and 6 correspond to approximate total scores on the
EC-17 of 1, 59, and 98, respectively
Table 3 Pearson correlations between the EC-17 and other measures
in total sample
Measure Expected r Observed r
PEPPI-5 0.5–1.0 0.55**
GSES 0.3–0.5 0.26**
AIMS2 Support 0.3–0.5 -0.34**
SF-36 MCS 0.3–0.5 0.39**
SF-36 PCS 0.0–0.3 0.14*
NRS Pain 0.0–0.3 -0.21**
EC-17 17-item effective consumer scale, PEPPI-5 5-item perceived
efficacy in patient–physician interactions scale, GSES general self-
efficacy scale, AIMS2 arthritis impact measurement scales 2, SF-36
medical outcomes study 36-item short form, MCS mental component
summary, PCS physical component summary, NRS numerical rating
scale
* P \ 0.05, ** P \ 0.01
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The association with general self-efficacy was just below
the cut-off value for moderate correlation.
Discussion
EC-17 scores were normally distributed, and the results of
both CFA and Rasch analysis supported the unidimen-
sionality of the scale, indicating that item scores can be
summed to create a single total score. The latter is in
accordance with previous studies that used principal com-
ponent analyses [6, 10].
The high internal consistency of the EC-17 corresponds
to the ability to discriminate between 3 and 4 distinct levels
of skills [25]. However, measurement precision was not
equally high across the underlying trait. On a group level,
the EC-17 had sufficient precision across a wide range of
scores. However, it was adequate for individual-level
comparisons only in persons with moderate and lower
levels of skills. Although it may be desirable to have a
measure that specifically targets patients with lower skills,
this also suggests that the EC-17 may lack discriminatory
power in patients with relatively high levels of skills. Since
a sample size of approximately 240 persons has been
shown to provide accurate estimates of item and person
locations in Rasch analyses, even for measures with poor
targeting, these results are likely to be quite robust [37].
However, no other studies have used Rasch analyses for the
current 17 items, and this finding should be further inves-
tigated in other populations.
Test–retest reliability was adequate, but lower than
previously found [10]. It is possible that we used a more
strict ICC model [38] or that the time interval was too long
to assure that no inter-individual variation occurred.
Finally, with the exception of general self-efficacy, all
hypothesized correlations were confirmed, supporting the
convergent and discriminant validity of the scale.
Given the relatively low response rate and the differ-
ences in both demographic and clinical characteristics
between the OA and FM patients, the current findings
should be interpreted with some caution and be cross-val-
idated in other samples of musculoskeletal patients.
In conclusion, this study suggests that Dutch EC-17 is a
valid and reliable measure of effective health consumer
skills in patients with musculoskeletal conditions. Future
studies should further examine its sensitivity to change in a
clinical trial specifically aimed at improving the skills and
behaviours deemed necessary for effective consumers,
before the scale can be fully endorsed as an outcome
measure for evaluating self-management interventions.
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